1492 Capital Management LLC Has $3.59 Million Stake in DocGo Inc. (NASDAQ:DCGO)

1492 Capital Management LLC decreased its stake in shares of DocGo Inc. (NASDAQ:DCGO) by 0.7% during the 4th quarter, HoldingsChannel.com reports. The firm owned 847,479 shares of the company’s stock after selling 5,833 shares during the quarter. DocGo accounts for 1.7% of 1492 Capital Management LLC’s holdings, making the stock its 20th largest position. 1492 Capital Management LLC’s holdings in DocGo were worth $3,593,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in DCGO. JPMorgan Chase & Co. increased its stake in DocGo by 151.1% during the third quarter. JPMorgan Chase & Co. now owns 109,855 shares of the company’s stock valued at $365,000 after acquiring an additional 66,097 shares during the period. Matrix Asset Advisors Inc. NY acquired a new stake in shares of DocGo during the 4th quarter worth approximately $424,000. Rhumbline Advisers increased its position in shares of DocGo by 4.5% during the fourth quarter. Rhumbline Advisers now owns 142,762 shares of the company’s stock valued at $605,000 after purchasing an additional 6,204 shares during the period. WCM Investment Management LLC increased its position in shares of DocGo by 64.2% during the fourth quarter. WCM Investment Management LLC now owns 4,314,071 shares of the company’s stock valued at $18,637,000 after purchasing an additional 1,687,100 shares during the period. Finally, Harbor Capital Advisors Inc. raised its stake in shares of DocGo by 37.5% in the fourth quarter. Harbor Capital Advisors Inc. now owns 1,331,928 shares of the company’s stock valued at $5,647,000 after purchasing an additional 363,391 shares in the last quarter. Institutional investors and hedge funds own 56.44% of the company’s stock.

DocGo Stock Performance

Shares of NASDAQ:DCGO opened at $2.12 on Friday. The company’s fifty day moving average is $3.36 and its 200-day moving average is $3.81. DocGo Inc. has a 52 week low of $2.10 and a 52 week high of $5.68. The company has a market capitalization of $216.20 million, a PE ratio of 7.57, a P/E/G ratio of 14.16 and a beta of 1.12.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on DCGO shares. Deutsche Bank Aktiengesellschaft lowered shares of DocGo from a “buy” rating to a “hold” rating and lowered their price target for the company from $5.00 to $2.85 in a report on Friday, February 28th. Needham & Company LLC reiterated a “buy” rating and set a $4.00 target price on shares of DocGo in a research report on Tuesday, April 8th. Finally, Stifel Nicolaus dropped their price target on shares of DocGo from $6.50 to $5.50 and set a “buy” rating for the company in a research report on Friday, February 28th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat, DocGo currently has a consensus rating of “Moderate Buy” and a consensus price target of $4.89.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.